| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5981483 |
Compositions comprising modulators of cytokines of the TGF-.beta. superfamily |
Nov. 9, 1999 |
| 5981493 |
Method of treating humans infected with human immunodeficiency virus |
Nov. 9, 1999 |
| 5976540 |
Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
Nov. 2, 1999 |
| 5977057 |
Thrombosis prophylaxis for factor V.sup.LEIDEN carriers |
Nov. 2, 1999 |
| 5977062 |
Glycopeptide antibiotic derivatives |
Nov. 2, 1999 |
| 5977063 |
Alkylated hexapeptides |
Nov. 2, 1999 |
| 5977070 |
Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
Nov. 2, 1999 |
| 5972880 |
Method of treatment of osteoarthritis with interleuken-1 receptor antagonist |
Oct. 26, 1999 |
| 5972886 |
Megakaryocyte differentiation factor |
Oct. 26, 1999 |
| 5972889 |
Method for inhibiting the proliferation of epithelial lens cells and implantable lens therefor |
Oct. 26, 1999 |
| 5968899 |
Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption |
Oct. 19, 1999 |
| 5965122 |
Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors |
Oct. 12, 1999 |
| 5965523 |
Method for enhancing transplanted tissue using scatter factor |
Oct. 12, 1999 |
| 5962406 |
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
Oct. 5, 1999 |
| 5962411 |
Human growth hormone variants and methods of administering same |
Oct. 5, 1999 |
| 5958401 |
Method of using IL-11 for treating psoriasis |
Sep. 28, 1999 |
| 5955100 |
Prodrugs their preparation and use as pharmaceuticals |
Sep. 21, 1999 |
| 5955420 |
Rse receptor activation |
Sep. 21, 1999 |
| 5955422 |
Production of erthropoietin |
Sep. 21, 1999 |
| 5951973 |
Use of interleukin-4 (IL-4) to treat rheumatoid arthritis |
Sep. 14, 1999 |
| 5952212 |
Protein tyrosine phosphatase |
Sep. 14, 1999 |
| 5952293 |
Receptor derived peptides involved in inhibition of receptor internalization in response to ligand binding |
Sep. 14, 1999 |
| 5948402 |
Method of using IL-11 for treating antibiotic induced diarrhea |
Sep. 7, 1999 |
| 5948407 |
Oral induction of tolerance to parenterally administered non-autologous polypeptides |
Sep. 7, 1999 |
| 5948426 |
Method and article to induce hematopoietic expansion |
Sep. 7, 1999 |
| 5948750 |
Conjugates useful in the treatment of prostate cancer |
Sep. 7, 1999 |
| 5948752 |
Suppressory agents against hypercoagulation |
Sep. 7, 1999 |
| 5948895 |
Process for producing a glycosylated amino compound |
Sep. 7, 1999 |
| 5942210 |
Methods for lyoprotecting a macromolecule using tricine |
Aug. 24, 1999 |
| 5942229 |
Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent |
Aug. 24, 1999 |
| 5939382 |
Reducing agent for reductive alkylation of glycopeptide antibiotics |
Aug. 17, 1999 |
| 5939390 |
Pharmaceutical composition |
Aug. 17, 1999 |
| 5932214 |
Treatment for inflammatory bowel disease with VLA-4 blockers |
Aug. 3, 1999 |
| 5932537 |
Method for attenuating a cellular response to IL-1 |
Aug. 3, 1999 |
| 5932538 |
Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses |
Aug. 3, 1999 |
| 5932542 |
Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
Aug. 3, 1999 |
| 5928636 |
Use of IL-12 and IFN.alpha. for the treatment of infectious diseases |
Jul. 27, 1999 |
| 5928645 |
Extracted substance having anti-HIV activity |
Jul. 27, 1999 |
| 5929028 |
Liquid gonadotropin containing formulations |
Jul. 27, 1999 |
| 5925344 |
Pharmaceutical composition and uses therefor |
Jul. 20, 1999 |
| 5925351 |
Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
Jul. 20, 1999 |
| 5925619 |
Formulation for peptide release |
Jul. 20, 1999 |
| 5922320 |
Recombinant proCVF |
Jul. 13, 1999 |
| 5919444 |
Method for decreasing severity of acute and chronic pancreatitis |
Jul. 6, 1999 |
| 5919754 |
Method of inhibiting fibrinogen binding to endothelial cells with fibrinogen gamma chain peptides |
Jul. 6, 1999 |
| 5919756 |
Amides |
Jul. 6, 1999 |
| 5919757 |
Aqueous pharmaceutical preparations of G-CSF with a long shelf life |
Jul. 6, 1999 |
| 5919758 |
Modified polypeptides with altered biological activity |
Jul. 6, 1999 |
| 5919759 |
Use of scatter factor to enhance angiogenesis |
Jul. 6, 1999 |
| 5916559 |
Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection |
Jun. 29, 1999 |
|
|
|
